Amrix Articles
Mylan confirms first-to-file Amrix patent challenge
8 December 2008
Cephalon swings back to profit in 3rd qtr
1 December 2008
Cephalon and Eurand sue Mylan and Barr over generic Amrix
1 December 2008
Cephalon exceeds guidance for 2nd qtr
11 August 2008
Eurand narrows nine-month loss to $2.3M
3 December 2007
Stock Commentary - New York - week to August 27, 2007
3 September 2007
Cephalon to acquire North American Amrix rights
3 September 2007
Showing 1-10 of 10 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
